$LITS
Lite Strategy, Inc.
A volume-weighted average price line from the last reported earnings date through today.
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
- CEO
- Mr. Justin J. File CPA
- Employees
- 4
- Headquarters
- San Diego, CA
- Sector
- Healthcare
- Industry
- Biotechnology
- Website
- litestrategy.com
Key stats
- Market Cap
- $33.68M
- P/E Ratio
- —
- Avg Volume (3M)
- 265.45K
- EPS
- -$2.08
- Day's Range
- $0.96 – $1.00
Fundamentals as of Sep 01, 2026